Personalis Inc.

Products

Category

Product

Brand

Description

Liquid Biopsy Research Tools, Services and Diagnostics (BIO150E)

NeXT Personal		NeXT Personal is a tumor-informed liquid biopsy test used to identify cancer recurrence and minimum residual disease ("MRD"). It provides ultra-high analytical sensitivity that leads the industry, which we believe enables earlier cancer identification than other methods.
NeXT Dx		NeXT Dx is a thorough tumor profiling test that provides matched tumor-normal analysis and unlocks the complete transcriptome (RNA) and exome (DNA). This test increases the chances of discovering a successful treatment or clinical study.

This information is available for BCC Research members only.

Already a Member? Sign In Become a Member

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment